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Abstract
Background: In Italy in 2004, a very restrictive law was passed on medically assisted reproduction (MAR) (Law 40/
2004) that placed Italy at the most conservative end of the European spectrum. The law was widely criticized and
many couples seeking MAR brought their cases before the Italian Civil Courts with regard to pre-implantation
genetic diagnosis (PGD), donor insemination and the issue of consent. Ten years on, having suffered the blows
of the Italian Constitutional Court, little remains of law 40/2004.
Discussion: In 2009, the Constitutional Court declared the maximum limit of the number of embryos to be produced
and transferred for each cycle (i.e. three), as stated in the original version of the law, to be constitutionally illegitimate.
In 2014, the same Court declared as unconstitutional the ban on donor insemination, thus opening the way to
heterologous assisted reproduction. Heterologous MAR is therefore perfectly legitimate in Italy. Finally, in 2015 a further
ruling by the Constitutional Court granted the right to access MAR to couples who are fertile but carriers of genetic
diseases. However, there is still much room for criticism. Many couples and groups are still, in fact, excluded from MAR.
Same-sex couples, single women and those of advanced reproductive age are, at the present time, discriminated against
in that Italian law denies these subjects access to MAR.
Summary: The history of Law 40/2004 has been a particularly troubled one. Numerous rulings have, over the years,
dismantled much of a law constructed in violation of the rights and autonomy of women and couples. However, a
number of troubling issues still exist from what is left of the law and the debate is still open at national and transnational
level regarding some of the contradictions and gaps in the law highlighted in this article. Only by abolishing the final
prohibitions and adopting more liberal views on these controversial yet crucial issues will Law 40/2004 become what it
should have been from the start, i.e. a law which outlines the ‘rules of use’ of MAR and not, as it has been until now, a
law of bans which sets limits to the freedom to reproduce.
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Background
In 2004, the Italian parliament promulgated a law (law
40/2004) on medically assisted reproduction (MAR).
Over the years, all previous attempts to introduce legis-
lation in this field had failed because of bitter conten-
tion, in both the Italian cultural and juridical fields,
between those who consider it necessary to have rigor-
ous and detailed legislative control and those who regard
only minimal legal intervention necessary in relation to
the access and use of MAR [1].
It had become apparent over the years that some sort
of regulation of MAR was necessary in Italy. Firstly,
there was a highly competitive commercial environment
with little regulation or supervision prior to the approval
of the law [2]. Moreover, also prior to the law, Italian
judges were frequently required to rule on cases of
disownment of paternity subsequent to MAR [3], post-
humous insemination [4], and surrogate motherhood
[5]. Since there was no specific law to regulate these sen-
sitive issues, juridical outcomes often differed.
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The Italian legislature preferred to lay down a very re-
strictive law [6] that placed Italy at the most conserva-
tive end of the spectrum in Europe [2].
The law begins with the statement that recourse to
MAR is allowed only in order to help solve reproductive
problems arising as a result of sterility or infertility, so as
to guarantee the rights of all people involved, including
those of the conceived child. Since protection of the
child born from MAR was the chief concern, the law
prohibited paternal disownment. Furthermore, acknow-
ledgement of the child born from MAR was made com-
pulsory for the mother. The law provided the same
rights to children born under MAR techniques as to
children conceived naturally [1]. It set up a national
register of authorized centres for MAR techniques and
established strict technical and safety requisites for the
centres themselves. The register collects the data from
most of the fertility centres, and monitors the safety and
the effectiveness of MAR procedures. A constant quality
check on both the operators’ professionalism and the ad-
equacy of the equipment and applied technologies of the
authorized centres was guaranteed. This is a valuable
aspect of the law since it undoubtedly provides a guaran-
tee for women undergoing MAR.
Originally, the law contained several bans, as well as
subjective requirements for couples who could access
MAR. Couples had to be adults of different genders, of
potentially fertile age and affected by sterility or infertil-
ity. They had to be married or living together and both
living. Gamete donation and surrogate motherhood
were banned. The law also established that a maximum
of three embryos could be produced and used in one
‘sole and simultaneous implant’, forbidding, at the same
time, the cryopreservation of embryos, except when
implantation was temporally impossible due to the




The law was widely criticized [7–12] and Italian Courts
heard more than 30 challenges to various aspects of the
law itself [13]. In particular, many Italian couples applied
the Civil Courts to be granted access to PGD and donor
insemination [13].
Strict interpretations of both the law and the Ministry
of Health’s subsequent guidelines led to infertile couples
affected by genetic diseases being denied the right to
resort to PGD. Over the years, rulings from many Italian
Civil Courts (Court of Cagliari, Court of Florence, 2007)
[14] have recognized the right of infertile couples affected
by genetic diseases to access PGD. Through PGD it is pos-
sible to define the genetic composition of embryos prior
to embryo transfer. Chromosomal abnormalities, X-linked
diseases or single gene disorders are the well-known med-
ical indications for PGD [15]. Scientific debate widened
to include other controversial uses such as inherited
cancer predispositions [16], human leukocyte antigens
(HLA) typing used to select (an) embryo(s) for intra-
uterine transfer with a view to giving birth to an un-
affected HLA matching sibling [17], sex-selection for
non-medical reasons [18], all of which sparked heated
ethical discussion [19, 20].
In Europe at the time, national regulations differed
across the board. In some countries, such as Germany
and Switzerland, PGD was prohibited by law, whereas in
France, the United Kingdom, Spain, Denmark, and
Belgium it was permitted. In countries such as Finland
and Portugal, PGD was practised without government
regulations [15].
Within this international scientific and legislative
background, the Italian Constitutional Court in 2009
finally declared that the maximum limit of three em-
bryos was constitutionally illegitimate, as was the
consequent obligation to implant all three embryos
produced, thus opening the way for infertile couples
to resort to PGD [21].
The consequences were not slow in coming, and
resulted in deep changes on the Italian reproduction
scene [22, 23]. The official figures for 2012 (Ministry of
Health) showed a change in the application of MAR pro-
cedures compared to the period before the 2009 Consti-
tutional Court ruling: an increase in cycles by embryo
thawing techniques and a decrease in fresh technique
cycles, compared to a steady increase in these cycles in
previous years. Thawing and freezing procedures in-
creased for embryos and decreased for oocytes. Analysis
shows that following legalization, the number of referrals
asking for PGD significantly increased [24, 25]. These
results strongly indicate that Italian women and couples
contemplating a future pregnancy would consider the
use of PGD.
PGD was a particularly troubled issue. Until 2015,
couples who were fertile but carriers of genetic disease
were discriminated against, in that the Italian law denied
these couples access to MAR and PGD, which could
only be carried out as part of MAR procedures following
the 2009 ruling of the Constitutional Court. Couples
who were fertile but carriers of genetic disease brought
the question of their right to obtain PGD to the atten-
tion of Italian Civil Courts (Court of Salerno, 2010). Judges
allowed these fertile couples to resort to assisted
reproduction, and above all, to PGD. In 2012 the European
Court of Human Rights (ECtHR) (28 August 2012) af-
firmed that the prohibition to access MAR for fertile
couples violated article 8 of the European Convention on
Human Rights (ECHR) and condemned Italy [26, 27]. Re-
cently, the Court of Rome has questioned the constitutional
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legitimacy of forbidding access to fertile couples who are
carriers of transmissible genetic disease which, in fact, pre-
vents aware and responsible procreation. Civil judges
underlined the fact that the limit of access to MAR for
fertile couples violates the right of such couples to health
and autonomy as well as the right to procreate. In such
cases, in an attempt to fulfil a legitimate desire to have a
child unaffected by a serious genetically transmissible dis-
ease, the couple, and particularly the woman, must embark
on a natural pregnancy knowing that she might have to
abort, with increased risk for her physical and mental
health. On 5 June 2015, the Constitutional Court ruled that
also fertile couples who are carriers of transmissible genetic
disease have the right to access MAR and PGD.
Donor insemination
In 2010 and 2011, following the requests of infertile cou-
ples, the Civil Courts of Milan, Florence and Catania
questioned the prohibition of gamete donation imposed
by law 40/2004 and referred this issue to the Constitu-
tional Court [13]. In April 2014, the Court (n. 162/2014)
condemned as unconstitutional the ban on heterologous
fertilization. Until this judgment, the restrictions im-
posed by the law had driven many infertile Italian cou-
ples to choose to go abroad so as to have wider access to
assisted procreative treatments [28–30]. A 2010 study
showed that of the six countries studied, Italy was in first
place for cross-border reproduction care: Italian patients
numbered 31.8 % of the total [31]. This figure has
remained constant since the first study by the national
Observatory on Procreative Tourism, testifying to the fact
that the demand for infertility treatments in Italy has not
received an adequate response [32]. In 2011, at least 4,000
Italian couples travelled abroad: half of these found it ne-
cessary to leave Italy because they sought donor insemin-
ation; the other half left for no apparent reason to have
treatment which was also available in Italy. This trend has
remained constant since the law came into force when, in
a single year, there was an almost 200 % increase in the
number of Italian couples who went abroad for reproduct-
ive reasons. This phenomenon constitutes a reproductive
‘exile’ [33] in that Italian infertile couples feel barred from
accessing MAR in their home country.
In the rulings mentioned above, Italian judges raised
doubts regarding the constitutional legitimacy of the ban
on donor insemination imposed by the law. All infertile
couples should have an equal opportunity to resort to
the most effective MAR procedures so as to resolve their
inability to have children. Because of this ban, couples
affected by infertility which could not be treated unless
by gamete donation were denied the right to satisfy their
desire for a child and make their own procreative
choices. The ban on sterile couples resorting to gamete
donation was, therefore, a violation of personal liberty,
autonomy and the right to comprehensive healthcare for
women that must include birth control, abortion and
sexual and reproductive health. Furthermore, this ban
represented a great disparity in health care, creating a
gap between couples who could, legitimately, fulfil their
desire for a child and achieve full reproductive health
through approved assisted reproduction and the more
numerous group whose rights were denied because they
could not resort to gamete donation. This was also a vio-
lation of the Italian Constitution (art. 2) which ensures
equal rights to all citizens, equal medical care (art.32),
and also of the National Health System law which guar-
antees comprehensive healthcare for all citizens without
discrimination. On the contrary, blatant discrimination
exists, on an economic basis, between couples with fer-
tility problems: only those with economic means to seek
treatment abroad can fulfil their desire to have a child.
The poignancy of the quests of infertile Italian couples
for heterologous MAR is further demonstrated by the
fact that immediately following the Constitutional Court
judgment on heterologous MAR, there were approxi-
mately 3,500 queries from couples to access donor in-
semination at the Italian CeCOS centres (centres for the
study and preservation of human oocytes and sperm)
[34], once again reflecting the dissatisfaction of infertile
women and couples regarding the deficiencies in their
home country.
The response of the constitutional judges was un-
equivocal. A couple’s decision to become parents and to
form a family is an expression of their fundamental free-
dom to self-determination which concerns both personal
and family matters. The decision on whether or not to
have a child affects the most intimate and untouchable
part of the individual. As such, this decision must be in-
coercible, as long as it does not endanger other constitu-
tional values, and even if it involves resorting to MAR
procedures with donors.
In the judgment of April 2014, the Constitutional
Court ruled that gamete donation techniques were im-
mediately applicable within the regulatory framework
currently in force. There is no danger of a legislative
void since all the unchanged/unrepealed parts of law 40/
2004 remain in force. Heterologous MAR is therefore
perfectly legitimate ‘even if only in different-sex couples,
married or cohabiting, and only in potential childbearing
age women’. However, many factors may still hinder
women’s and couples’ access to heterologous MAR.
Recommended changes
There are several controversial aspects of Law 40/2004,
some of which derive from the original form of the law,
including criteria for accessing therapy, and withdrawal
of consent to MAR procedures.
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The Italian law states that access to MAR should be
limited to adults of different genders, of fertile age,
with medically-certified sterility or infertility. They
should be married or living together, and both living.
In 2007, following a Ministerial Decree, a sexually
transmissible disease in the man was deemed to be a
condition of sterility such as to guarantee access to
MAR for these couples.
However, many couples and groups are still excluded
from MAR in Italy. Same-sex couples, single women,
post-mortem insemination, surrogacy and gestational
carriers are still banned. These are challenging and
unresolved topics non only in Italy [35] but every-
where [36, 37].
Whether this discriminates against single women or
homosexual couples, or whether it is an affirmation of
the rights of children born from MAR to grow up in a
traditional family with both male and female role models
for their healthy psychosocial development, is still a mat-
ter for debate. There are studies which demonstrate that
raising children in family units with homosexual parents
does not have a significant negative impact on cognitive
development and function, emotional adjustment, gen-
der identity or behaviour when compared with children
of heterosexual couples or single mothers [38, 39]. How-
ever, there is some debate about the risks for the child.
This mainly concerns the psychosocial risks of growing
up in a non-nuclear familial environment. Critics fear
negative repercussions for the wellbeing of the child
(and, later, of the adult) [40]. However, results from
empirical studies so far are to a large extent reassuring
[41]. In the recent position statement of ESHRE’s Task
Force on Ethics and Law, it is reported that ‘assisted
reproduction in non-standard situations is morally
sound in many cases. There is no good reason to a
priori dismiss access in these situations – such categor-
ical dismissal would imply discrimination’ [40].
In its present form, though with changes introduced
following the numerous decisions by Italian judges, law
40/2004 still reinforces and protects a very narrow con-
cept of the ‘appropriate’ family unit as being one com-
posed of children with heterosexual parents who are
married or in a stable cohabiting relationship. This is in
opposition to the rights and autonomy of women and
couples in relationships to reproductive freedom,
stressed as the basic right of all couples and individuals
to make free and accountable decisions. And yet in Italy,
despite the impact of prevalent Catholic thought, and
albeit more slowly than in other countries, profound
changes are occurring in the traditional family, with a
higher number of single-parent families, single person
households, childless couples, and same-sex couples
[42]. A recent Italian study suggested that, despite the
societal pressures that Italian same-sex couples have to
face, these relationships appear resilient, and fare well
both overall and in the specific domains of functioning
compared to heterosexual couples both in Italy and the
United States [43].
There is a lack of consensus among Italian healthcare
professionals regarding the bans imposed by the law. For
example, in a recent cross-sectional study involving 224
healthcare professionals working with assisted reproduction
in Brazil, Italy, Germany and Greece, it was reported that
even in Germany and Italy, where insemination is illegal for
single women, almost a quarter of the professionals
(24.4 %) claimed that they would agree to perform the pro-
cedure [44]. This highlights once again the gap that ex-
ists not only between Law 40/2004 and Italian couples,
but also between the law and Italian healthcare profes-
sionals. Thus, the law does not seem to reflect the new
social needs and the ongoing cultural changes that are
now present in Italy.
A further point of great concern is the withdrawal of
consent to MAR procedures. The law underlines the
need for informed consent, which must be expressed in
writing by both members of the couple. This can be re-
voked by either person until the time the oocyte is in-
seminated. From this moment on, the physician may
decide not to proceed solely on medical grounds. The
law states (art.6) that the woman cannot withdraw
consent to the technique from the time of fertilization.
Respect for autonomy is a central principle in Italian
healthcare, and it implies that patients should not be
coerced into medical treatments. The idea that the pa-
tient’s autonomy is something valuable that has to be
protected emanates from the Italian Constitution (arti-
cles 2,3, 13, and 32). Article 6 of Law 40 is a striking
example of how this law infringes upon women’s auton-
omy and appears to be the result of assigning a higher
value to the protection of embryos than to the interests
and rights (including autonomy) of infertile women. As
consent withdrawal is still not permitted by the law, the
protection of women's right to autonomy and health re-
quires careful consideration. We argue that respect for
women’s personal decisions constitutes a reason to op-
pose this article, whose dubious legitimacy has been
highlighted in recent years by the Civil Court of Florence
(2008). However, at the time of writing there has been
no definitive ruling by the Italian Constitutional Court
on this matter. Finally, women who are not allowed to
withdraw their consent to the technique from the time
of fertilization, may paradoxically, once pregnancy has
begun, make the decision to terminate the pregnancy,
under the Italian law (194/1978) on voluntary termination
of pregnancy. However, women's experiences of abortion
are complex; confronting an unwanted pregnancy is not
easy and deciding to terminate it is anything but straight-
forward. Abortion is a stressful experience [45], and the
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risks of both surgical and medical abortion for women’s
health are well known [46]. Thus it seems that prohibiting
the withdrawal of consent is still deeply problematic for
the health and autonomy of Italian women.
Other issues have arisen as a result of the recent lifting
of the ban on heterologous MAR. Following the decision
of the Constitutional Court, and in the silence of the na-
tional legislators who have not yet seen fit to intervene,
Italian regions have drawn up a document setting out
operational guidelines and homogeneous clinical indica-
tions to facilitate the immediate granting of the right to
heterologous MAR throughout the country.
The following are the key points: adequate technical
provisions for the selection of donors and the safety of
the donation in compliance with the EU Tissue and
Cells Directive (EUTCD) and the supplementary tech-
nical directives 2006/17/EC and 2008/86/EC; the estab-
lishment of a national register for tracing donor/child;
the unpaid and voluntary nature of gamete donation; the
introduction of a maximum limit of births from the
same donor; the introduction of a minimum and max-
imum age for donors; the anonymity of gamete donors.
The debate on open or anonymous gamete donation
continues unabated [47, 48], While anonymous gamete
donation has long been the preferred practice, a new
focus on the rights and interests of donor-conceived
children has led a number of countries to shift towards
an open-identity system. Recently, the Ethics Committee
of the American Society for Reproductive Medicine,
while acknowledging that these are very personal choices
and that the people involved can have very different
opinions [49], came out in favour of disclosure to the
child of donor conception and, if available, any charac-
teristics of the donor that may serve the best interests of
offspring [50]. Some authors have analysed this issue in
terms of asymmetries of harm and benefit for both chil-
dren and donors.
The open system recognizes the child’s right to know
his/her biological lineage in that it is fundamental to the
donor offspring’s wellbeing and understanding of his/her
identity, as well as to choices made later in life [51–53].
Furthermore, disclosure is the basis for open and honest
communication with children in order to avoid oppres-
sive family secrets which may have possible negative
repercussions for family relationships [54–56]. There
are, however, those who would argue that in case of
gamete donation there are compelling reasons for not
telling the child. A reason that is often given is that it is
not in the best interests of the child to know [57]. If
facts about a child’s conception spread throughout the
family and school environment, this could lead to isola-
tion and stigmatization [58]. Finally, some authors affirm
that parents have a right to privacy which would be vio-
lated were the details of conception to be released [59].
An evolving debate is now underway regarding the other
parties involved, and the possible right of the donor to
information about the offspring conceived by their dona-
tion is emerging [60]. The exchange of medical informa-
tion between donors and donor-conceived individuals
could ensure the donor’s health since the latter’s access
to medical information regarding their offspring (for ex-
ample in the case of genetic disease) may obviously be
relevant for clinical reasons [61]. It has been argued that
information regarding offspring would allow donors to
feel positive about their donation, thus improving the
psychological and social wellbeing of donors themselves
[60]. This does not automatically entail parental disclos-
ure [60]; however, identifying information could allow
the opportunity for donors to have contact with their
offspring [60, 62]. It could be beneficial for donors will-
ing to know their offspring, although this could open
risky scenarios in which potential dangers for offspring
have to be taken into account if social parents have not
informed the child about his/her conception, and if off-
spring and parents are not willing to meet donors [60].
In spite of this complex debate and of the international
trends, Italy is moving towards a system of anonymous
gamete donation with a maximum limit of 10 children
born from each donor.
In conclusion, Law 40/2004 has been profoundly
changed over the years following the judgments of the
Italian Constitutional Court that have guaranteed more
people the right to access MAR, PGD and donor in-
semination. However, since issues such as the ban of
withdrawal of consent to the procedure until the time
the oocyte is inseminated, and the further liberalization
of the actual criteria to access MAR (single women, les-
bian and gay couples) still remain unresolved, the deci-
sions of the Constitutional Court are unlikely to end
the debate on MAR.
Conclusions
The story of Law 40/2004 has been a particularly trou-
bled one [63]. Numerous rulings have, over the years,
dismantled much of a law constructed in violation of
women’s and couples’ rights and autonomy. There have
been many steps forward; yet the Italian law still does
not guarantee that the right to raise a family, which is
protected by the Italian Constitution, is supported by
the State’s duty to offer the best treatments available for
all women and couples seeking a child. A number of
troubling issues still arise from what is left of the law
and the debate is still open at national and transnational
level on some of the gaps in the law highlighted by this
article. The issues surrounding assisted reproduction are
the common outcome of advanced nations’ technological
and cultural development, and so need to be studied from
a transnational perspective, keeping in mind the global
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landscape of cross-border reproductive care [64]. Within
Europe at least 24,000-30,000 cycles are performed annu-
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